Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05657990 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Post Operative Urinary Retention (POUR) Following Thoracic Oncological Surgery

StatusRecruiting
PhaseEarly Phase 1
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 5 months later Dec 2026 → Jun 2027
See other at-risk trials from Hackensack Meridian Health

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion pushed from Dec 2026 to Jun 2027v13
  2. 2 versions Re-verified since Oct 21, 2025, no change to tracked fieldsv11-v12
  3. Site details revised at 3 of 4 sitesv10
  4. Site contacts updated at 3 of 4 sitesv9
  5. Re-verified, no change to tracked fieldsv8
Show 6 earlier versionsHide 6 earlier versions
  1. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Apr 1, 2023 to Apr 3, 2023
    • Site details revised at 4 of 4 sites
    v7
  2. Start date: Mar 1, 2023 to Apr 1, 2023v6
  3. Start date: Jan 20, 2023 to Mar 1, 2023v5
  4. Site contacts updated at 2 of 4 sitesv4
  5. Study sites: 1 to 4
    • Start date: Dec 20, 2023 to Jan 20, 2023
    v3
  6. Phase: Not applicable to Early Phase 1
    • Primary endpoints revised (5)
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a feasibility study looking at whether the use of Tamsulosin could lower the high incidence of postoperative urinary retention (POUR) in older men who undergo an oncological thoracic surgical procedure for suspected or confirmed cancer. In addition, the study will try to identify the time of resumption of presurgical urinary function post Tamsulosin administration.
Trial Details
NCT Number NCT05657990
Lead Sponsor Hackensack Meridian Health
Conditions
(from sponsor)		 Urinary Retention
Related terms Urinary Retention
Enrollment 46 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov